NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Glia, the leader in customer interaction technology, today announced that ...

Charles River Labs has a strong history in supporting neuroscience and neurodegenerative diseases across all stages of drug ...

Glia, the leader in customer interaction technology, today announced a partnership with $1.4 billion-asset Frankenmuth Credit Union (FCU) to unify member interactions across digital channels, voice ...

A neurosurgeon has shared a number of simple lifestyle measures that can help keep your brain healthy, and reduce the risk of ...

“It’s not about how much you eat, it’s about what you eat,” he adds. “These are the nutrients that are helpful and not ...

“The astrocyte response to AD neuropathology is complex and nonlinear, both along spatial and temporal axes,” Das told Alzforum. She hopes the dataset, which is freely available online, will be a ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Neuroscientist Rogier Min from the Amsterdam UMC has collaborated with Christiaan Levelt's lab from the Netherlands Institute for Neuroscience and discovered how brain cells may react to cannabis, ...

Researchers discovered that cannabis affects brain development by interacting with CB1 receptors on astrocytes, not just neurons.

Vigil Neuroscience's stock dropped after Alector's AL002 failed in Alzheimer's, raising concerns about VG-3927's efficacy.